October 30, 2026

FDA revises warnings on 3 estradiol patches

Cardiovascular, breast cancer, and dementia statements are removed, but other risk information remains.

MDSpire News

October 30, 2026

Monthly fasting cycles may be feasible in T2D

Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate.

MDSpire News

October 30, 2026

Top 10 evidence-based essentials in ObGyn

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

MDSpire News

October 30, 2026

High TIRADS may signal cancer despite benign cytology

Patients with higher ultrasound risk classifications had about 5.7 times the adjusted odds of postoperative malignancy in a selected surgical cohort.

MDSpire News

October 21, 2026

Oral spironolactone may hold edge in female acne

Topical treatment showed lesion reductions with minimal systemic exposure, but small, heterogeneous studies leave its clinical role uncertain.

MDSpire News

October 21, 2026

FDA clears new generic weekly menopause patch

The once-weekly patch provides a generic alternative for menopausal symptoms and osteoporosis prevention.

MDSpire News

October 19, 2026

Depression, anxiety symptoms may be common in T1D

National survey data show a greater mental health symptom burden among adults with type 1 diabetes vs. those with type 2 diabetes or no diabetes.

MDSpire News

October 06, 2026

NNS beverages may match water in weight control

Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.

MDSpire News

October 06, 2026

ACP puts hormone therapy first for menopause symptoms

Estrogen-based therapy is now recommended first for vasomotor symptoms, with SNRIs, SSRIs, gabapentin, and neurokinin receptor antagonists reserved for later lines.

MDSpire News

October 05, 2026

Prenatal metformin not linked to developmental risk

Adjusted findings showed no association with developmental vulnerability overall or across any of the 5 developmental domains.

MDSpire News